NCT00189280View on ClinicalTrials.gov

Aldara for the Treatment of Large and/or Multiple sBCC

PHASE3CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Carcinoma, Basal Cell
Interventions
DRUG

Imiquimod

cream 5%, 5 days out of seven, for 6 weeks

Trial Locations (1)

87042

Service de DermatologieHôpital Dupuytren, Limoges

All Listed Sponsors
lead

MEDA Pharma GmbH & Co. KG

INDUSTRY

NCT00189280 - Aldara for the Treatment of Large and/or Multiple sBCC | Biotech Hunter | Biotech Hunter